TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Jupiter Life Line Hosp L
JLHL

Jupiter Life Line Hosp L Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 64/100 · Average See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹265.65

Change

-2.15 (-0.8%)

Open

₹269.8

Prev. Close

₹267.8

Day High

₹269.8

Day Low

₹262.35

Volume Analysis

Traded

58,557

Delivered

28,452

Delivery %

48.59%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (22.0%)

Weaknesses (0)

No signal for this stock

Opportunities (3)

  • •Strong 3-year EPS growth (31.9%)
  • •Strong 3-year revenue growth (18.9%)
  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹276.96 ₹273.38 ₹269.51 ₹265.93 ₹262.06 ₹258.48 ₹254.61
Fibonacci ₹273.38 ₹270.53 ₹268.78 ₹265.93 ₹263.08 ₹261.33 ₹258.48
Camarilla ₹267.7 ₹267.02 ₹266.33 ₹265.93 ₹264.97 ₹264.28 ₹263.6

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-81.0%

1 Week

-3.59%

1 Month

-11.86%

3 Months

-81.3%

6 Months

-78.7%

1 Year

-82.41%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹79.21

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

11.63%

Net margin 12.07% × asset turnover 0.63x × equity multiplier 1.53x

Company Overview

Sector

Healthcare

Market Cap

₹8,706 Cr

P/E (TTM)

45.6

ROE

13.1%

Book Value

₹47.1

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 25 Sep 2026. Not investment advice.

TopFund Analysis

Jupiter Life Line Hosp L lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 64/100. The strongest factor is Growth (98/100), while Valuation (15/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (22.0%). Strong 3-year EPS growth (31.9%).

TopFund Score — Fundamentals Quality

64/100 — Average

Data confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

95

Growth

98

Valuation

15

Cash Flow

71

Corporate Governance

61

Momentum

33

Institutional Ownership

69

Business Quality

71

Risk & Volatility

50

Liquidity

31

From Screener.in

  • +Company has delivered good profit growth of 143% CAGR over last 5 years

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Closure of Trading Window 25 Sep 25 Sep
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 15 Sep

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR) Regulations 2015.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript 7 Aug 07 Aug
Announcement under Regulation 30 (LODR)-Newspaper Publication 03 Aug

Intimation of Newspaper Publication for Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30,2026.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 03 Aug

Audio link shared for Q1 FY27 investor call held August 3, 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 243 263 273 291 289 335 333 337 353 394 365 388 411
Expenses + 190 202 211 228 223 257 256 257 275 301 282 299 332
Operating Profit 53 61 62 63 65 78 76 80 78 92 83 89 79
OPM % 22.0% 23.0% 23.0% 22.0% 23.0% 23.0% 23.0% 24.0% 22.0% 23.0% 23.0% 23.0% 19.0%
Other Income + 4 3 8 10 7 7 7 7 13 11 3 11 11
Interest 12 12 1 1 1 1 3 6 8 8 8 9 13
Depreciation 11 11 11 10 11 14 14 18 21 21 22 23 26
Profit before tax 34 41 58 62 60 70 67 63 62 74 57 68 51
Tax % -60.0% 19.0% 25.0% 27.0% 26.0% 26.0% 22.0% 28.0% 29.0% 23.0% 25.0% 26.0% 26.0%
Net Profit + 54 34 44 45 45 52 52 45 44 57 42 50 38
EPS in Rs 2 1 1 1 1 2 2 1 1 2 1 2 1
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 463 486 733 893 1,073 1,302 1,500 1,558
Expenses + 379 419 580 691 831 999 1,156 1,214
Operating Profit 84 67 153 201 242 303 343 344
OPM % 18.0% 14.0% 21.0% 23.0% 23.0% 23.0% 23.0% 22.0%
Other Income + 0 4 4 8 22 25 37 35
Interest 26 39 44 42 26 11 33 37
Depreciation 26 31 36 39 42 57 88 93
Profit before tax 33 2 77 129 195 261 260 249
Tax % 10.0% 248.0% 34.0% 43.0% 10.0% 26.0% 25.0% —
Net Profit + 30 -2 51 73 177 194 194 188
EPS in Rs 1 0 2 3 5 6 6 6
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 4.0% 3.0% 3.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 186 188 243 309 1,103 1,291 1,479
Borrowings + 272 426 495 469 0 393 584
Other Liabilities + 94 124 120 151 112 168 235
Total Liabilities 603 789 909 986 1,281 1,917 2,363
Fixed Assets + 435 630 684 720 718 978 1,384
CWIP 10 26 27 29 74 185 129
Investments 2 7 3 2 17 507 486
Other Assets + 156 126 195 235 473 247 364
Total Assets 603 789 909 986 1,281 1,917 2,363
Equity Capital 51 51 51 57 66 66 66

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 74 123 137 176 115 267 268
Cash from Investing Activity + -43 -295 -84 -94 -246 -497 -442
Cash from Financing Activity + -32 184 32 -51 128 297 136
Net Cash Flow -1 12 85 31 -3 66 -38
CFO/OP 106 198 95 97 68 109 97
Free Cash Flow 46 -118 46 100 29 -60 -234

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 40.91% → 40.91%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 41.8% 41.19% 40.76% 39.18% 36.79% 33.31% 33.43% 33.51% 33.08% 33.17% 33.6% 33.2%
Promoters 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91%
FII 4.62% 3.96% 4.17% 6.06% 8.84% 10.04% 10.04% 9.77% 9.06% 8.48% 8.48% 9.37%
DII 12.69% 13.92% 14.16% 13.85% 13.46% 15.75% 15.64% 15.82% 16.97% 17.44% 17.01% 16.51%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Jupiter Life Line Hosp L (this stock) 8,706 45.6 5.65 13.1%
Aarti Pharmalabs Limited 8,472 39.4 3.99 8.59%
Thyrocare Tech Ltd 9,022 49.9 15.41 28.4%
Suven Life Sciences Ltd 9,466 — 14.96 -81.5%
Bliss Gvs Pharma Ltd 7,486 54.4 6.23 11.8%
Innova Captab Limited 7,402 48.1 6.78 13.7%
Sanofi India Limited 7,232 16.4 8.4 47.1%

Which Mutual Funds Hold Jupiter Life Line Hosp L?

Frequently Asked Questions about Jupiter Life Line Hosp L

Community Sentiment

What are other investors saying about Jupiter Life Line Hosp L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.